Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 28.12M P/E - EPS this Y 94.10% Ern Qtrly Grth -
Income -30.5M Forward P/E -3.56 EPS next Y -276.70% 50D Avg Chg -
Sales 37.34M PEG - EPS past 5Y - 200D Avg Chg -4.00%
Dividend N/A Price/Book 39.37 EPS next 5Y - 52W High Chg -78.00%
Recommedations 2.50 Quick Ratio 1.75 Shares Outstanding 21.40M 52W Low Chg 37.00%
Insider Own 0.35% ROA -35.66% Shares Float 10.15M Beta 2.10
Inst Own 82.85% ROE -284.32% Shares Shorted/Prior 538.39K/547.74K Price 0.75
Gross Margin -57.02% Profit Margin -81.67% Avg. Volume 195,945 Target Price 24.79
Oper. Margin -272.91% Earnings Date Mar 25 Volume 136,557 Change -2.57%
About Harpoon Therapeutics, Inc.

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candidate, including HPN328, which is in Phase I/II clinical trials for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors; and HPN217 that is in Phase I clinical trials for the treatment of multiple myeloma. Its preclinical stage product is HPN601 for the treatment of multiple solid tumor indications. It has a discovery collaboration and license agreement with AbbVie Biotechnology Ltd. to develop and commercialize products that incorporate its proprietary TriTAC platform technology together with soluble T cell receptors. The company was incorporated in 2015 and is headquartered in South San Francisco, California. As of March 11, 2024, Harpoon Therapeutics, Inc. operates as a subsidiary of Merck Sharp & Dohme LLC.

HARP Chatroom

User Image TalkMarkets Posted - 1 month ago

Week In Review: Curon Out-Licenses T-Cell-Engager To Merck For $700 Million Upfront $DSKYF $HARP $WXXWY https://talkmarkets.com/content/global-markets/week-in-review-curon-out-licenses-t-cell-engager-to-merck-for-700-million-upfront?post=457831

User Image John_D_Stockefeller Posted - 07/22/24

@John___wick44 So sorry for your many losses. My story, with $HARP and $AMAM both getting bought out at a nice premium on the same day, is different.

User Image Azzoz Posted - 2 months ago

$CNTX $HARP

User Image georgeqi Posted - 2 months ago

$CNTX $HARP acquired by Merk with just one pipeline for 650M similar like recent acquired CT95, so $CNTX could worth 4×-6× if it is acquired by other big companies, $8-$12 is reasonable price in 2025 once 2 phase 1 results are out..

User Image John_D_Stockefeller Posted - 2 months ago

@telomerase @Chemaster btw, i was in both $HARP and $AMAM from a couple of bucks, to buyouts well into in the $20s. Have a couple right now that are set up for similar outcomes, imo.

User Image John_D_Stockefeller Posted - 3 months ago

@Trubach Definitely not comparing the stock or company. Just pointing out that contrary to message board belief systems, a reverse split does not always spell doom. Many companies do quite well after a r/s, depending on all other variables. I had been holding and adding $HARP for almost a year, when they announced a r/s forthcoming last fall. I believed in them enough to more than triple down when the price plunged. In January they were bought out for a nice premium. Cha-Ching.

User Image John_D_Stockefeller Posted - 3 months ago

@jcooptechit Welp, not always true. I bought, added to, and held both $AMAM and $HARP through a period of about 15 months. Both endured severe ups and downs, and HA RP had a reverse split along the way. i got in early, and they both got bought out in January. Made a tidy sum on both. Many small would do fine, continue to grow and prosper…..if day traders and flippers jumped off a cliff.

User Image John_D_Stockefeller Posted - 05/21/24

@John___wick44 Bought $HARP, added, held. Held through 1:10 reverse split, tripled down. Woke up and logged on after the year-long + endeavor to see it got BO at many multiples of my entries. Drugs in pipeline, $16 PT, other reasons to hold. Plus, up close to 50% currently.

User Image John_D_Stockefeller Posted - 4 months ago

@Billy_Striebeck BTW, I was in deep with $HARP well over a year ago, held and added, right through a 1:10 reverses split. Afterwards, I tripled down, and held. the share price recovered, rose again steadily, and I believe it was in January, I woke up to news of it being bought out. Was about a 600% gain from the lows I had bought at, both prior to, and after the reverse split. Not all reverse splits are created equally. Holding 100 shares. I’ll be okay. Have a great day!

User Image GSMITH10107 Posted - 4 months ago

$BCAB I also wanted to add to this - CEO Jay Short is no joke - go look at his background and history. he also put his money where his mouth is - he owns 3.5 million shares of BCAB .. $CTMX is trading at approx 300 million market cap in the same sector.. why is BCAB trading only at 150 million market cap? two assets are in phase 2, while CTMX is only in phase 1.. then they would argue CTMX partnership with amgen / data right around the corner well guess what - $BCAB has multiple data readouts the next 60 days and CEO has essentially guaranteed a Big Pharma partnership in December.. so why half the valuation of $CTMX ????????? makes no sense to me I think it would be ludicrous to sell my shares here.. just my honest opinion what if it does make a $harp $janx type move.. worth a gamble FOR ME

User Image BiotechValues Posted - 5 months ago

$SRZN @raticals brought up a good point on $HARP. Despite doing a large PIPE Oct 23, 2023, they were bought out ~3 months later by Merck on Jan 8, 2024. From a tiny $15M market cap before the PIPE, to $680M buyout in a few months. Did HARP know Merck was interested, but not ready? Or was it a surprise after the PIPE? https://www.streetinsider.com/Corporate+News/Harpoon+Therapeutics+Inc.+%28HARP%29+Announces+Up+to+%24150+Million+Private+Placement/22298383.html

User Image Bull_Bros Posted - 5 months ago

Reminiscing $HARP- had a nice gain here, but boy did we get screwed by that PIPE financing -for longs who held before RS. Rigged game 🤔

User Image Yourmatefromdownunder Posted - 6 months ago

$HARP Woohoo$$$ Cash pouring in! Also got lots more in $3’s and $4’s Holding but have stops in…… just in case!

User Image svong1175 Posted - 6 months ago

$CLRB Possibly heading the same way here as $HARP? Sept 1st 2023 trading closed $10.70 1:10 RSS announced Dipped to $3.30 by mid October 2023 Back up to high $10s by early January 2024 Acquired by Merck for $23 on January 8th 2024 Maybe, maybe not 🤷

User Image Solfer Posted - 6 months ago

$MCRB Possibly heading the same way here as $HARP? Sept 1st 2023 trading closed $10.70 1:10 RSS announced Dipped to $3.30 by mid October 2023 Back up to high $10s by early January 2024 Acquired by Merck for $23 on January 8th 2024 Maybe, maybe not 🤷

User Image Rehypothecation Posted - 6 months ago

$HARP Merck $MRK buys 21,397,205 shares of Harpoon Therapeutics $HARP for $492,135,712 on 3-11-2024

User Image insiderbuyingselling Posted - 6 months ago

$HARP new insider buying: 21397205 shares. http://insiderbuyingselling.com/?t=HARP

User Image rob8311 Posted - 6 months ago

$HARP So when does the money hit?

User Image momeymaker1 Posted - 6 months ago

$HARP unbelievable

User Image Stock_Titan Posted - 6 months ago

$MRK $HARP Merck Completes Acquisition of Harpoon Therapeutics, Inc. https://www.stocktitan.net/news/MRK/merck-completes-acquisition-of-harpoon-therapeutics-dkhx2hesk5ag.html

User Image tradethehalt Posted - 6 months ago

$HARP trade halt (T12) was alerted to our Members at 7:50pm EST. Halt price: $23.00 Vol: 6.62M.

User Image Mergerbrief Posted - 6 months ago

$HARP $MRK - Shareholder Vote $HARP mergerbrief.com

User Image svong1175 Posted - 6 months ago

@kylebraun21 What if the share holders voted and ask for more $ and the deal fell through . What happen to $HARP will it maintain the price of $23 or drop back to down ?

User Image kylebraun21 Posted - 6 months ago

$HARP if HARP is being bought out, is there any reason to hold onto my shares Vs just selling right now?

User Image DailyStocksPicks Posted - 6 months ago

The Direxion Daily S&P Biotech Bear 3X Shares ($LABD), known for its aim to deliver three times the inverse exposure to the S&P Biotechnology Select Industry Index, may be considered oversold due to bullish trends in the biotechnology sector. Groundbreaking innovations, significant venture capital inflows, and the doubling of deal values have fueled optimism, drawing substantial investment into biotech. Regulatory advancements and the sector's resilience amidst economic downturns further enhance its appeal, contributing to a positive outlook. However, this optimism for biotech can exert downward pressure on LABD's price, as its performance is inversely related to the sector's success, highlighting the complex dynamics at play between sectoral developments and the valuation of leveraged inverse ETFs​​​​​​ $VRTX $NBIX $ALKS $HARP For more details https://youtu.be/QDW75yHzRo0

User Image LabPsycho Posted - 6 months ago

$CTMX I am seeing some similarities between CTMX Probody technology and $HARP, $JANX and $HOWL masking technology. Look at how well these stocks have performed recently.

User Image John_D_Stockefeller Posted - 02/24/24

@Earth4thewin What I am hoping for, we'll see. Why I bought Z. I got in $AMAM in the 2 - 3 range, and got out in the 13 range prior to buyout. Put the funds mostly into adds for $HARP, after the r/s, in the 3.00 - 11.00 range, and it got bought out for $23 the same day as did Ambrx. So, nothing lost by the switch. Hoping that history can repeat with some of the same management team, albeit one that I have had wavering belief in. Just hoping they deliver....GL

User Image Mlerro01 Posted - 02/22/24

$HARP why hasn’t this moved ?

User Image StockInvest_us Posted - 02/22/24

Signal alert: $HARP - Oversold Trend Short (Undervalued) https://stockinvest.us/l/IWkAqdJFGt

User Image boomup04 Posted - 02/22/24

$HARP so if 22.50 was the ceiling how the heck did it go to 22.98??? New to all this. Thanks

Analyst Ratings
Citigroup Neutral Feb 26, 24
TD Cowen Market Perform Jan 16, 24
HC Wainwright & Co. Neutral Jan 8, 24
Oppenheimer Outperform Jan 5, 24
HC Wainwright & Co. Buy Dec 13, 23
TD Cowen Outperform Nov 20, 23
Citigroup Buy Oct 24, 23
Citigroup Buy Sep 18, 23
HC Wainwright & Co. Buy Sep 14, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
HUNT RONALD Director Director Mar 23 Buy 1000.00 10,000 10,000,000 10,000 03/27/23